N@N

Tiago Fauth Initiated (VRDN) at Buy and Held Target at $51 on, Jun 14th, 2023

Tiago Fauth of Credit Suisse, Initiated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $51 on, Jun 14th, 2023.

Tiago has made no other calls on VRDN in the last 4 months.

There are 8 other peers that have a rating on VRDN. Out of the 8 peers that are also analyzing VRDN, 0 agree with Tiago's Rating of Hold.

These are the ratings of the 8 analyists that currently disagree with Tiago

---

• Gregory Renza of "RBC Capital" Initiated at Buy and Held Target at $44 on, Tuesday, May 30th, 2023
• Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $44 on, Wednesday, May 10th, 2023
• Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $48 on, Wednesday, May 10th, 2023
• Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $40 on, Wednesday, May 10th, 2023
• Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Wednesday, May 10th, 2023
• Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $47 on, Monday, April 10th, 2023
• Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $49 on, Thursday, March 30th, 2023
• Michael Higgins of "Ladenburg Thalmann" Reiterated at Strong Buy and Held Target at $40 on, Thursday, March 9th, 2023

Contributing Sources

---